These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15209409)

  • 1. Biomarkers of cancer risk and therapeutic benefit: new technologies, new opportunities, and some challenges.
    MacGregor JT
    Toxicol Pathol; 2004; 32 Suppl 1():99-105. PubMed ID: 15209409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of regulatory toxicology: impact of the biotechnology revolution.
    MacGregor JT
    Toxicol Sci; 2003 Oct; 75(2):236-48. PubMed ID: 12883082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in cancer screening, research and detection: present and future: a review.
    Kumar S; Mohan A; Guleria R
    Biomarkers; 2006; 11(5):385-405. PubMed ID: 16966157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging technologies for improved stratification of cancer patients: a review of opportunities, challenges, and tools.
    Lamlertthon W; Hayward MC; Hayes DN
    Cancer J; 2011; 17(6):451-64. PubMed ID: 22157289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 'Omic' technologies to study humans exposed to benzene.
    Smith MT; Vermeulen R; Li G; Zhang L; Lan Q; Hubbard AE; Forrest MS; McHale C; Zhao X; Gunn L; Shen M; Rappaport SM; Yin S; Chanock S; Rothman N
    Chem Biol Interact; 2005 May; 153-154():123-7. PubMed ID: 15935808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of biomarkers in developing new therapies for vascular disease.
    Nambi V; Ballantyne CM
    World J Surg; 2007 Apr; 31(4):676-81. PubMed ID: 17387551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technologies in molecular genetics: the impact on epilepsy research.
    Helbig I
    Prog Brain Res; 2014; 213():253-78. PubMed ID: 25194493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging biomarker technologies.
    Gunn L; Smith MT
    IARC Sci Publ; 2004; (157):437-50. PubMed ID: 15055310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development.
    Tan DS; Thomas GV; Garrett MD; Banerji U; de Bono JS; Kaye SB; Workman P
    Cancer J; 2009; 15(5):406-20. PubMed ID: 19826361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of genomics in conservation and reproductive sciences.
    Johnson WE; Koepfli K
    Adv Exp Med Biol; 2014; 753():71-96. PubMed ID: 25091907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging in the clinical arena.
    Jaffer FA; Weissleder R
    JAMA; 2005 Feb; 293(7):855-62. PubMed ID: 15713776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and toxic torts: dismantling the risk-injury divide.
    Grodsky JA
    Stanford Law Rev; 2007 Apr; 59(6):1671-734. PubMed ID: 17593590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology in oncology--the AstraZeneca perspective.
    Campbell DA; Carmichael J; Chopra R
    Pharmacogenomics; 2004 Dec; 5(8):1167-73. PubMed ID: 15584883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ; Chan DW
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future of personalized medicine in oncology: a systems biology approach.
    Gonzalez-Angulo AM; Hennessy BT; Mills GB
    J Clin Oncol; 2010 Jun; 28(16):2777-83. PubMed ID: 20406928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.